For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using ...

For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment ...

For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using ...

For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a ...

For patients with type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with an increased risk for gastroesophageal reflux disease (GERD) and its complications compared ...

No increased risk of thrombotic events identified despite rise in erythrocytosis among sodium-glucose cotransporter 2 ...

SGLT2 inhibitors, compared with GLP-1 RAs, were associated with lower risks for osteoarthritis and joint replacement surgery among patients with T2D.

More data, this time from a large observational study, are bolstering the idea that glucagon-like peptide-1 (GLP-1) receptor agonists offer neuroprotective and cerebrovascular benefits beyond what can ...

Experts reveal how Mounjaro actually works on your body after people took to social media complaining over 'hair loss' side ...

It isn't easy finding high-yield dividend growth stocks when the market is at an all-time high. Shares of Novo Nordisk and ...

Patients prescribed drugs to help them lose weight may experience a rebound in weight gain after halting their prescription, ...

We can't have it both ways. If we want more cutting-edge drugs, we have to protect the property rights that make them ...